Latest filing published 15 Feb 2011 for SAVIENT PHARMACEUTICALS INC, €39k.
Insider track record
No signal scores available.
Paul Hamelin: trading record in brief
Paul Hamelin appears in our data through filings on Savient Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 53 filings cover trades dated from 23 May 2006 to 14 February 2011.
On the market, this insider has only sold: 29 sales, €896k in total. Other entries cover 10 share grants and 14 option exercises. 2011 to date brings no purchases and 1 sale.
Most recently, on 15 February 2011, the filings show an open-market sale worth €39k in Savient Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul Hamelin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,371 shares@ US$9.89Common Stock, $.01 par value per shareSEC:0001181431-11-010543:0
- 76,394 shares@ US$20.27Common Stock, $0.01 par value per shareSEC:0001181431-10-047356:0
- 34,699 shares@ US$20.27Common Stock, $0.01 par value per shareSEC:0001181431-10-047356:1
- 1,433 shares@ US$13.80Common Stock, $.01 par value per shareSEC:0001181431-10-009619:0
- 5,492 shares@ US$13.80Common Stock, $.01 par value per shareSEC:0001181431-10-009619:1
- 1,981 shares@ US$13.36Common Stock, $.01 par value per shareSEC:0001181431-09-055987:0
- 4,000 shares@ US$15.00Common Stock, $.01 par value per shareSEC:0001181431-09-044021:0
- 1,179 shares@ US$5.76Common Stock, $.01 par value per shareSEC:0001181431-09-027015:0
- 50,000 shares@ US$5.94Common Stock, $.01 par value per shareSEC:0000950117-09-000241:0
- 1,777 shares@ US$5.77Common Stock, $.01 par value per shareSEC:0000950117-09-000241:1
- 50,000 shares@ US$5.94Common Stock, $.01 par value per shareSEC:0000950117-09-000227:0
- 1,777 shares@ US$5.77Common Stock, $.01 par value per shareSEC:0000950117-09-000227:1
- 6,333 shares@ US$4.53Common Stock, $0.1 par value per shareSEC:0000950117-08-001521:0
- 2,450 shares@ US$4.71Common Stock, $0.1 par value per shareSEC:0000950117-08-001521:1
- 65 shares@ US$4.83Common Stock, $0.1 par value per shareSEC:0000950117-08-001521:2
- 9,500 shares@ US$5.17Common Stock, $0.1 par value per shareSEC:0000950117-08-001328:0
- 2,926 shares@ US$5.17Common Stock, $0.1 par value per shareSEC:0000950117-08-001328:1
- 1,232 shares@ US$24.09Common Stock, $.01 par value per shareSEC:0001230295-08-000437:0
- 1,231 shares@ US$5.11Common Stock, $.01 par value per shareSEC:0001230295-08-000437:1
- 1,231 shares@ US$25.25Common Stock, $.01 par value per shareSEC:0001230295-08-000437:2
- 5,000 shares@ US$5.11Common Stock, $.01 par value per shareSEC:0001230295-08-000436:2
- 1,928 shares@ US$12.11Common Stock, $.01 par value per shareSEC:0001230295-08-000432:0
- 1,928 shares@ US$24.89Common Stock, $.01 par value per shareSEC:0001230295-08-000432:1
- 5,000 shares@ US$12.11Common Stock, $.01 par value per shareSEC:0001230295-08-000432:2
- 5,000 shares@ US$25.75Common Stock, $.01 par value per shareSEC:0001230295-08-000432:3
25 of 49 declarations
